reference/26869698

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26869698

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	427
issn	1936-8798
issueIdentifier	5
pageRange	422-427
publicationName	JACC: Cardiovascular Interventions
startingPage	422
bibliographicCitation	Costa JR, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, Maldonado G, Staico R, Siqueira D, Sousa AG, Bonan R, Sousa JE. 1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial. JACC Cardiovasc Interv. 2009 May;2(5):422–7. doi: 10.1016/j.jcin.2009.02.009. PMID: 19463465.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaaafdd9b401a8a19e8f73a9c8ecb5aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03a3213c0c607d788780b2e784daef3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe61d812643242f6d014f8f8377653ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c630a3414077c318bdd524771398ca61 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5716807c081341a2cd9acad5facd2b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36505870d301c6ef4f80f7fe5099020a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1efc5010a3fbfedea211093d47dfeb18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac60913bf95b42dbde37c0d5b203b5a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88ba3e318dd559497e54d9ad3fdd82ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7739e9bc89be58f2b8c3eb54894f94b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36eccd152a3f2b88cec9ff2e91720ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a5a0131637c176cadff737764fb3449
date	200905
identifier	https://doi.org/10.1016/j.jcin.2009.02.009 https://pubmed.ncbi.nlm.nih.gov/19463465
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35678 https://portal.issn.org/resource/ISSN/1936-8798
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial
discusses	http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0017208 http://id.nlm.nih.gov/mesh/M0027020 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0155432
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015906 http://id.nlm.nih.gov/mesh/D054855 http://id.nlm.nih.gov/mesh/D003324Q000188 http://id.nlm.nih.gov/mesh/D020123Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D001241 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003324Q000000981 http://id.nlm.nih.gov/mesh/D000077144 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007362 http://id.nlm.nih.gov/mesh/D013988Q000031 http://id.nlm.nih.gov/mesh/D001026 http://id.nlm.nih.gov/mesh/D013988Q000627 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011108 http://id.nlm.nih.gov/mesh/D014463 http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D023903 http://id.nlm.nih.gov/mesh/D017023 http://id.nlm.nih.gov/mesh/D017886 http://id.nlm.nih.gov/mesh/D020123Q000008 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D003324Q000628
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14781 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8094

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075

Total number of triples: 74.